Research Paper Volume 14, Issue 24 pp 9951—9968
A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature
Figure 5. Validation the reliability of the risk signature in the validation set (GSE2658). (A) summarizes the distribution of risk scores, the survival status of patients, and the expression of UPS genes in the training set. (B) A time-dependent ROC analysis for 1-, 3-, and 5-years OS prediction. (C) Survival analysis between low-risk and high-risk MM patients.